JHIU
UTHR icon

Janus Henderson Investors US’s United Therapeutics UTHR Stock Holding History

Janus Henderson Investors US’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.94M Buy
14,305
+7,863
+122% +$1.19M ﹤0.01% 930
2016
Q4 		$923K Sell
6,442
-2,754
-30% -$352K ﹤0.01% 1064
2016
Q3 		$1.09M Sell
9,196
-4,116
-31% -$495K ﹤0.01% 1026
2016
Q2 		$1.41M Buy
13,312
+1,933
+17% +$216K ﹤0.01% 955
2016
Q1 		$1.27M Sell
11,379
-23,021
-67% -$2.91M ﹤0.01% 958
2015
Q4 		$5.39M Sell
34,400
-115,900
-77% -$16.9M ﹤0.01% 803
2015
Q3 		$19.7M Buy
150,300
+128,400
+586% +$20.6M 0.02% 612
2015
Q2 		$3.81M Buy
+21,900
New +$3.94M ﹤0.01% 835
2014
Q4 		– Sell
-6,900
Closed -$888K – 1134
2014
Q3 		$888K Sell
6,900
-114,200
-94% -$11.8M ﹤0.01% 970
2014
Q2 		$10.7M Sell
121,100
-151,000
-55% -$14.5M 0.01% 664
2014
Q1 		$25.6M Buy
272,100
+41,700
+18% +$4.26M 0.02% 519
2013
Q4 		$26.1M Buy
230,400
+15,100
+7% +$1.36M 0.02% 499
2013
Q3 		$17M Buy
215,300
+3,100
+1% +$227K 0.02% 563
2013
Q2 		$14M Buy
+212,200
New +$13.7M 0.01% 566

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Investors US's UTHR Position: Q1 2017 in Review

Janus Henderson Investors US increased its United Therapeutics (UTHR) stake by 122% in Q1 2017, buying an estimated $1.19M and bringing the position to 14,305 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Janus Henderson Investors US first reported a position in UTHR in Q2 2013 and has held it in 14 quarters since. The position peaked at $26.1M in Q4 2013. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • Janus Henderson Investors US held 14,305 shares of United Therapeutics worth $1.94M as of Q1 2017.
  • Janus Henderson Investors US bought 7,863 United Therapeutics shares in Q1 2017, an estimated $1.19M.
  • United Therapeutics made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #930 holding.
  • Janus Henderson Investors US first reported a position in United Therapeutics in Q2 2013 and has held it in 14 quarters since.
  • Janus Henderson Investors US's United Therapeutics position peaked at $26.1M in Q4 2013.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.